Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy

Berrin Gunaydin; Zerrin Ozkose; Seyda Pezek

首页> 外文期刊>Journal of Anesthesia >Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy

【24h】

Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy

机译：重组激活因子VII和ε氨基己酸治疗Glanzmann血栓性衰弱患者鼻腔切除术

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Anesthesia》 |2007年第1期|106-107|共2页
作者
Berrin Gunaydin; Zerrin Ozkose; Seyda Pezek;
展开▼
作者单位

Department of Anesthesiology and Reanimation Faculty of Medicine Gazi University Besevler 06500 Ankara Turkey;

Department of Anesthesiology and Reanimation Faculty of Medicine Gazi University Besevler 06500 Ankara Turkey;

Department of Anesthesiology and Reanimation Faculty of Medicine Gazi University Besevler 06500 Ankara Turkey;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia [J] . Man-Chiu Poon Vascular Health and Risk Management . 2007,第5期

机译：重组人类激活因子VII（rFVIIa）在预防和治疗Glanzmann血栓性衰弱患者出血事件中的临床应用
2. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: A review of the literature [J] . RajpurkarM., ChitlurM., RechtM., Haemophilia: the official journal of the World Federation of Hemophilia . 2014,第4期

机译：重组活化因子VII在格兰兹曼血栓性衰弱患者中的应用：文献综述
3. Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia. [J] . Lombardo VT, Sottilotta G Clinical and applied thrombosis/hemostasis . 2006,第1期

机译：重组活化因子VII与去氨加压素联用可预防Glanzmann血栓衰弱患者的拔牙出血。
4. Acquired Glanzmann Thrombasthenia in a Patient with Myelodysplastic Syndrome [C] . A. Trummer, A. Tiede, R. Eisert Hemophilia Symposium . 2008

机译：在患有髓细胞增强综合征的患者中获得了Glanzmann血栓血管瘤
5. Characterization of a platelet Cys374Tyr GPIIIa mutation in a patient with Glanzmann thrombasthenia. [D] . Grimaldi, Christine Mary. 1996

机译：患有Glanzmann血虚症的患者血小板Cys374Tyr GPIIIa突变的特征。
6. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia [O] . Man-Chiu Poon 2007

机译：重组人类激活因子VII（rFVIIa）在预防和治疗Glanzmann血栓性衰弱患者出血事件中的临床应用
7. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia [O] . Man-Chiu Poon 2020

机译：使用重组活化因子VII与Glanzmann血栓血管血管患者
8. Treatment of an Acquired Coagulopathy with Recombinant Activated Factor VII in a Damage-Control Patient. [R] . Holcomb, J. B., Hoots, K., Moore, F. A. 2005

机译：在损伤控制患者中用重组活化因子VII治疗获得性凝血病。

Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy

著录项

相似文献

相关主题

期刊订阅